Published: Guidance, quality standards and advice
Showing 11 to 15 of 15
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Suspected cancer: recognition and referral | NG12 | ||
| Avelumab with axitinib for untreated advanced renal cell carcinoma | TA1120 | ||
| Overweight and obesity management | NG246 | ||
| Entrectinib for treating NTRK fusion-positive solid tumours in people 12 years and over (terminated appraisal) | TA1118 | ||
| Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia | TA1119 |